Biosystems modelling for in silico target validation: challenges to implementation

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.6, 2000-12, pp. : 699-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Target validation in silico: does the virtual patient cure the pharma pipeline?

By Alkema Wynand Rullmann Ton van Elsas Andrea

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 635-638

Informa Healthcare

Access to resources Recommend Favorite

Hammerhead ribozymes for target validation

By Goodchild John

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 235-247

Informa Healthcare

Access to resources Recommend Favorite

Drug Discovery and Target Validation

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

From in vivo to in vitro/in silico ADME: progress and challenges

By Van de Waterbeemd Han

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

The Challenges Involved in Modeling Toxicity Data In Silico: A Review

Current Drug Metabolism, Vol. 18, Iss. 9, 2012-03 ,pp. : 1266-1291

Bentham Science Publishers

Access to resources Recommend Favorite